Sunday, November 22, 2026

Subscribe

EconomyEdition UgandaUganda

Uganda steps up local foot-and-mouth vaccine production

With Egypt’s support, Uganda plans to open a veterinary vaccine plant in Kampala to combat foot-and-mouth disease. The project aims to protect livestock and limit supply disruptions.

Veterinary service counter in Kampala, where an administrative officer hands a file to a Ugandan livestock farmer

A health battle with economic stakes

In Uganda’s livestock-farming areas, an outbreak of foot-and-mouth disease is about more than sick animals. It can shut markets, delay sales and undermine already irregular incomes. In a country where livestock plays a major role in the rural economy, vaccination is therefore also a matter of productive sovereignty.

Uganda, whose capital is Kampala, is pursuing an approach that would take the health response to a new scale: producing more vaccines locally, with technical support from Egypt. The project concerns foot-and-mouth disease, a highly contagious viral illness that mainly affects cattle, but also goats, sheep and pigs.

A partnership embedded in Uganda’s strategy

The project did not emerge from nowhere. Since 2024, Kampala and Cairo have been working together on local production of foot-and-mouth disease vaccines, with the involvement of Uganda’s National Agricultural Research Organisation, or NARO. This approach is part of Uganda’s public policy on animal disease control, led by the Ministry of Agriculture, Animal Industry and Fisheries, better known by its acronym MAAIF.

On 26 July 2026, during a working visit to Cairo, Ugandan minister Frank Tumwebaze discussed a timetable for starting work on a veterinary vaccine manufacturing plant for foot-and-mouth disease in Uganda. Ugandan official communications confirm that the aim is to build local capacity while retaining Egyptian technological support.

The cooperation is concrete. NARO has said Egypt is to supply vaccine doses as part of immediate support for the ongoing campaign, while scientists from both countries are already working on a quadrivalent formula, covering four virus serotypes.

What the vaccine project involves

The technical plan is based on clear complementarity. According to NARO, Egypt already produces vaccines targeting serotypes O, A and SAT 2, which are present in Uganda. Kampala, for its part, wants to manufacture a component tailored to serotype SAT 1, also detected in the country. Combining the two components is intended to produce a quadrivalent vaccine better suited to Uganda’s livestock.

The authorities are also talking about training. Egyptian scientists are to support their Ugandan counterparts in vaccine production techniques. Here, too, the stakes go beyond the laboratory. If skills development succeeds, Uganda will reduce its dependence on imports and secure a supply chain often vulnerable to logistical pressures or delivery delays.

The strategy comes as the country steps up its response. The government announced the launch, in July and then August 2026, of its first national mass vaccination campaign against foot-and-mouth disease. The programme provides for two rounds a year. It is based on a cost-sharing system in which the state covers vaccines, storage, transport, the cold chain, surveillance and veterinary supervision, while farmers pay a reduced contribution per dose.

A disease that affects herds and households

Foot-and-mouth disease remains one of the most disruptive animal diseases in Uganda. The FAO said that more than 40 districts reported outbreaks in 2023. It also noted that new episodes continued to occur in 2024 and 2025, demonstrating the persistence of the health threat.

The available figures give a sense of the problem. Studies by Ugandan researchers, cited by local media, point to a mortality rate of 37.8% among calves in some infection settings. Other estimates show that outbreaks can cut household income from livestock farming by 63% and reduce sales of animal products by 70%. These figures help explain why vaccination is seen as an economic tool as well as a veterinary one.

The FAO also notes that livestock is important to rural livelihoods in the country, and that a significant proportion of households depend on animals. In this context, each outbreak costs more than livestock. It also means lost opportunities for sales, transport and informal credit, and sometimes reduced access to school or medical fees.

What this means for Kampala, the districts and East Africa

For the Ugandan state, the planned production plant addresses three urgent needs. First, availability. Second, cost, since emergency imports remain more expensive than production under national control. Finally, adaptation, as the vaccine will need to match the serotypes present in the country. This is a change in approach: more targeted, more industrial and potentially more sustainable.

For the districts, the impact will be even more direct. The FAO notes that outbreaks were widespread across the country in 2023. Foot-and-mouth disease spreads rapidly through the movement of animals, leaving local markets, transhumance routes and cross-border trade exposed. The national control strategy adopted in 2025 aims specifically to strengthen the regulation of animal movements between districts and across borders.

At regional level, the issue extends beyond Uganda. East Africa, organised around the East African Community, depends on livestock that is mobile and often crosses borders. When a country establishes local vaccine production capacity, it also sends a signal to its neighbours: livestock health security can no longer depend solely on imports or emergency measures. It must be built on research, production and surveillance.

This is where cooperation with Egypt takes on continental significance. It illustrates a model of skills transfer between African countries, without waiting for a technology corridor from elsewhere. If the timetable announced in Kampala holds, Uganda could become a benchmark in East Africa for the local manufacture of veterinary vaccines against foot-and-mouth disease. The next step to watch is straightforward: the signing of technical agreements, followed by the actual start of the work announced by the authorities.

Automatic translation. Original French version

The quiz

Edition UgandaUganda in five questions

5 questions